Clinical Trials Logo

Overweight and Obesity clinical trials

View clinical trials related to Overweight and Obesity.

Filter by:

NCT ID: NCT04621045 Completed - Clinical trials for Overweight and Obesity

Active You: Feasibility of a Unique Physical Activity Program to Prevent Diabetes and Heart Disease

Start date: October 27, 2020
Phase: N/A
Study type: Interventional

Individuals who are overweight/obese are more vulnerable to type 2 diabetes (T2D). Current evidence suggests that PA, even without dietary prescription, can be efficacious in preventing T2D. Yet most Americans, especially those who are overweight/obese, are not physically active. Socioenvironmental barriers to physical activity (PA) such as body image concerns and limited access to fitness facilities contribute to the low levels of PA observed in overweight/obese adults. Web-based PA programs have been developed to address these barriers, but the outcomes have been marginal. Qualitative studies suggest that individuals who are overweight/obese prefer PA programs that feature people they can relate to especially in body size, fitness status and age. Previously, the investigators have included these preferences in a technology-based Physical Activity for The Heart (PATH) intervention that leverages open source platforms, such as YouTube, to promote PA in any setting. In this application, the investigators propose to test the feasibility and preliminary efficacy of PATH in promoting PA and reducing cardiometabolic risk in adults who are overweight/obese and at high risk of diabetes. In Aim 1 the investigators will conduct a 12-week randomized clinical trial including 52 adults who are overweight/obese and at high risk of diabetes to assess the feasibility and acceptability of PATH. In Aim 2 investigators will examine the trend in PA and cardiometabolic risk change from baseline to post-intervention. This approach is innovative because it leverages open source technologies to provide low-cost, action-oriented PA resources that match the preferences of adults who are overweight/obese. This contribution will be significant because PATH could offer a convenient, enjoyable and scalable program that features "similar others" to promote PA in overweight/obese adults at high risk of diabetes.

NCT ID: NCT04618133 Recruiting - Clinical trials for Overweight and Obesity

Time-restricted Eating in Morning Chronotype

Start date: January 4, 2021
Phase: N/A
Study type: Interventional

Overweight and obesity are highly prevalent conditions worldwide, despite active research of new interventions over decades. Current interventions include medications or bariatric surgery, but these approaches cannot be used in all patients and require clear indications and a close multidisciplinary management. Therefore most patients and physicians rely on lifestyle interventions, focusing on a balanced diet and physical exercise. Recent studies have uncovered that energy metabolism is also regulated by circadian rhythms, which depend on spontaneous diurnal oscillations of the central clock, retinal sensing of ambient light, and daily feeding-fasting cycles. The chronotype has an influence on behavioral patterns, where some people describe that they are more alert in the morning or in the evening: The morning or evening chronotypes, respectively. However, in modern societies, many people are exposed to external cues in misalignment with their circadians clocks. The mismatch between the individual chronotype and the social/work life can lead to metabolic disorders. Time-restricted eating (TRE), i.e. energy intake limited to certain windows of time without restricting calories, is an appealing approach because it proposes to realign the circadian clocks with external cues provided by the timing of food intake, thus leading to better metabolic outcomes. The investigators speculate that the TRE intervention needs to be personalized to reach efficacy in a broader population. To tailor the TRE intervention to each individual and harmonize their eating patterns in accordance to their chronotype, the investigators plan to test early TRE vs. late TRE vs. active control in overweight and obese individuals with morning chronotype.

NCT ID: NCT04617405 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Hormonal and Inflammatory Changes During Pregnancy in Women With Glucose Metabolic Disorders.

HI-MET
Start date: January 11, 2021
Phase:
Study type: Observational

The first aim of this study is to describe maternal hormonal and inflammatory changes during pregnancy in women that differ metabolically (limited to women with type 2 diabetes, gestational diabetes and/or overweight). The second aim of this study is to examine maternal hormonal, inflammatory and metabolic factors associated with insulin sensitivity in human pregnancy.

NCT ID: NCT04614961 Recruiting - Clinical trials for Overweight and Obesity

Database Concerning Patients Consulting the Obesity Clinic

Start date: November 12, 2019
Phase:
Study type: Observational [Patient Registry]

A registry of individuals that visit the Obesity Clinic of the University Hospitals of Leuven will be established. The objective of this registry is to improve the knowledge about obesity, the treatment of obesity and its outcomes.

NCT ID: NCT04614233 Active, not recruiting - Clinical trials for Overweight and Obesity

Targeting the Gut-brain Axis to Facilitate Weight Loss in High Fat Diet Consumers

Start date: April 6, 2021
Phase: Phase 4
Study type: Interventional

The primary objective is to test if fat intake moderates the ability of oleoylethanolamide (OEA) to improve weight loss maintenance after the LEARN® weight loss program.

NCT ID: NCT04611477 Completed - Clinical trials for Overweight and Obesity

Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals

Obesity
Start date: September 28, 2020
Phase: N/A
Study type: Interventional

Evaluate the effect of Synbiotic 365 (Version 5 and 7) on body composition in overweight and obese individuals as measured by change in body mass index (BMI) and the percentage of body fat from Day 0 to Day 84 when compared to placebo by Dual Energy X-ray Absorptiometry scan (DEXA) for body composition (Body Mass Index, Lean Body Mass, Body Fat, Fat Free Mass).

NCT ID: NCT04589273 Recruiting - Clinical trials for Overweight and Obesity

The Effect of Alginate Supplementation on Weight Management

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

This project will assess the effect of the alginate (in a capsules) on the weight of generally healthy volunteers over a 12 week period. To achieve this, will recruit 150 (non-smoking) generally healthy volunteers to attend the study centre on four separate occasions. Volunteers will be randomly allocated into active or placebo arm of the trial, both will receive capsules with the same appearance. The volunteers will have their height, weight, waist circumference, body composition, and fasting levels of circulating glucose, triacylglycerol and cholesterol measured at each for the four visits.

NCT ID: NCT04586647 Completed - Obesity Clinical Trials

Attitudes Toward Food During a Weight Loss Intervention

Start date: November 4, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether the Noom Healthy Weight Program, a digital behavior change weight loss intervention, creates a positive relationship with food, compared to a waitlist control group.

NCT ID: NCT04583514 Recruiting - Metabolic Syndrome Clinical Trials

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

EAT 2
Start date: September 15, 2020
Phase: N/A
Study type: Interventional

Adipose, or fat, tissue is a plastic organ that retains the ability to expand and store excess calories during positive energy balance in humans. The capacity of subcutaneous (subQ) adipose tissue to expand and remodel is an important determinant of obesity-related health complications, and impaired expansion of subQ fat tissue is thought to contribute to the risk of diseases such as the Metabolic Syndrome (MetS) and type 2 diabetes mellitus (T2D). The objectives of the study are to evaluate the changes and mechanisms of (subQ) adipose tissue expandability that occur as a result of short-term weight gain and to investigate the effects on cardio-metabolic health outcomes. Findings from this study will provide new insight into the dynamics of adipose expansion and remodeling during changes in energy balance and how this may impact future fat tissue function and metabolic health.

NCT ID: NCT04581421 Completed - Diabetes Clinical Trials

The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid Content

LICARB
Start date: December 3, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate dietary compositions effect on liverfat measured by magnetic resonance imaging.